Letter: is body-mass index really associated with fibrosis regression during long-term nucleoside analogue therapy in chronic hepatitis B?

Aliment Pharmacol Ther. 2017 Feb;45(3):482. doi: 10.1111/apt.13885.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antiviral Agents
  • DNA, Viral
  • Hepatitis B virus / genetics
  • Hepatitis B, Chronic*
  • Humans
  • Lamivudine*

Substances

  • Antiviral Agents
  • DNA, Viral
  • Lamivudine